- Home
- ECG vs RNA Comparison
ECG vs RNA Comparison
Compare ECG & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECG
- RNA
- Stock Information
- Founded
- ECG 1995
- RNA 2012
- Country
- ECG United States
- RNA United States
- Employees
- ECG N/A
- RNA N/A
- Industry
- ECG
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- ECG
- RNA Health Care
- Exchange
- ECG NYSE
- RNA Nasdaq
- Market Cap
- ECG 3.1B
- RNA 3.6B
- IPO Year
- ECG N/A
- RNA 2020
- Fundamental
- Price
- ECG $64.16
- RNA $29.36
- Analyst Decision
- ECG Buy
- RNA Strong Buy
- Analyst Count
- ECG 3
- RNA 14
- Target Price
- ECG $73.00
- RNA $68.00
- AVG Volume (30 Days)
- ECG 323.4K
- RNA 1.4M
- Earning Date
- ECG 08-15-2025
- RNA 08-08-2025
- Dividend Yield
- ECG N/A
- RNA N/A
- EPS Growth
- ECG 14.34
- RNA N/A
- EPS
- ECG 2.98
- RNA N/A
- Revenue
- ECG $3,050,625,000.00
- RNA $8,927,000.00
- Revenue This Year
- ECG $9.73
- RNA N/A
- Revenue Next Year
- ECG $10.17
- RNA $156.80
- P/E Ratio
- ECG $21.09
- RNA N/A
- Revenue Growth
- ECG 11.77
- RNA N/A
- 52 Week Low
- ECG $31.38
- RNA $21.51
- 52 Week High
- ECG $77.93
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- ECG N/A
- RNA 44.84
- Support Level
- ECG N/A
- RNA $27.71
- Resistance Level
- ECG N/A
- RNA $30.52
- Average True Range (ATR)
- ECG 0.00
- RNA 1.35
- MACD
- ECG 0.00
- RNA -0.27
- Stochastic Oscillator
- ECG 0.00
- RNA 34.66
About ECG EVERUS CONSTRUCTION GROUP INC
Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.